期刊文献+

孤独症动物模型的研究进展 被引量:2

下载PDF
导出
摘要 孤独症,又称自闭症,这一概念最早是由瑞士精神病医生Eagen Bleuer提出的,而第一例关于孤独症的临床研究是由美国临床医学家Kanner在1943年首先报道[1]。儿童孤独症是一种较常见的严重的神经系统发育障碍性疾病,主要表现为儿童自幼开始在语言交流和非语言交流方面存在严重障碍、重复刻板行为等。
出处 《中国实验诊断学》 2012年第12期2339-2343,共5页 Chinese Journal of Laboratory Diagnosis
基金 国家自然科学青年基金(81101454) 吉林大学"985工程"基地研究项目(2011) 吉林大学创新项目(2011) 吉林大学第一医院儿科发展基金(2002)
  • 相关文献

参考文献39

  • 1Ratajczak HV. Theoretical aspects of autism: Causes A review [J].hnmunotoxicol, 2011,8 ( 1 ) : 68. 被引量:1
  • 2Atladettir HO, Thorsen P, stergaard L, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders[J]. Autism Dev Disord, 2010,40 (12) : 1423. 被引量:1
  • 3Patterson PH. Immune involvement in schizophrenia and autism: Etiology,pathology and animal models [J].Behav Brain Res, 2009,204 (2) : 313. 被引量:1
  • 4Boylan CB,Blue ME, Hohmann CF. Modeling early cortical sero- tonergic deficits in autisrn[J]. Behav Brain Res, 2007,176 (1) :94. 被引量:1
  • 5Kirsten TB, Chaves Kirsten GP, Chaible LM, et al. Hypoactivity of the central dopaminergie system and autistic-like behavior in- duced by a single early prenatal exposure to lipopolysaccharide [J].Neurosci Res,2012,90(10) :1903. 被引量:1
  • 6Atladottir HO,Thorsen P, stergaard L, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders[J]. Autism Dev Disord,2010,40(12) : 1423. 被引量:1
  • 7Lante F, Meunier J, Guiramand J, et al, Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation[J]. Hippocampus, 2008; 18(6) :602. 被引量:1
  • 8Beloosesky R, Gayle DA, Ross MG. Maternal N-acetylcysteine suppresses fetal inflammatory cytokine responses to maternal li- popolysaccharide[J]. Obstet Gyneco1,2006,195(4) : 1053. 被引量:1
  • 9Paintlia MK, Paintlia AS, Barbosa E, et al. N aeetylcysteine pre vents endotoxin-induced degeneration of oligodendrocyte progeni tors and hypomyelination in developing rat brain [J]. Neurosci Res,2004,78(3) :347. 被引量:1
  • 10Smith SE,Li J,Garbett K,et al. Maternal immune activation al ters fetal brain development through interleukin-6[J]. Neurosci, 2007,27(40) : 10695. 被引量:1

同被引文献38

  • 1European Medicines Agency. PRAC recommends strengthening therestrictions on the use of valproate in women and girls [ EB/OL].(2014-10-10 ) [ 2015-01 -08 ]. http://www. ema. europa. eu/ema/index. jsp. curl = pages/% 2011ew_% 20and _ events/news/2014/10/news _ detail _ 002186. jsp&mid = WCObOl ac058004d5d. 被引量:1
  • 2Dupuis RE, Lichtman SN, Pollack GM. Acute valproic acid over-dose. Clinical course and pharmacokinetic disposition of valproicacid and metabolites[ J]. Drug Saf, 1990, 5(1) : 65-71. 被引量:1
  • 3U. S. Kood and Drug Administration. FDA drug safety communi-cation :valproate anti-seizure products contraindicated for migraineprevention in pregnant women due to decreased IQ scores in ex-posed children [EB/OL]. (2013-05-06) [2015-01-08]. http://www. fda. gov/drugs/drugsafety/ucm350684. htm. 被引量:1
  • 4Iijscher W, Nau H. Valproic acid: metabolite concentrations inplasma and brain,anticonvulsant activity,and effects on GABAmetabolism during subacute treatment in mice [ J ]. Arch Int Phar-macodyn Ther, 1982, 257(1 ) : 20-31. 被引量:1
  • 5Sztajnkrycer MD. Valproic acid toxicity: overview and manage-ment [J]. J Toxicol Clin Toxicol, 2002 , 40(6) : 789-801. 被引量:1
  • 6Ghodke-Puranik Y, Thom CF, Lamba JK, et al. Valproic acidpathway: pharmacokinetics and pharmacodynamics [ J ]. Pharma-oogenet Genomics, 2013 , 23(4) : 236-241. 被引量:1
  • 7Loscher W, Wahnschaffe U, Honack D, et al. Effects of valproateand E-2-en-vaiproate on functional and morphological parametersof rat liver. 1. Biochemical, histopathological and pharmacokineticstudies[ J]. Epilepsy Kes, 1992 , 13(3) : 187-198. 被引量:1
  • 8Nagai G, Ono S, Yasui-Furukori N, et al. Formulations of val-proate alter valproate metabolism: a single oral dose kinetic study[J]. Ther Drug Monit, 2009, 31(5) : 592-596. 被引量:1
  • 9Nau H, Zierer R. Pharmacokinetics of valproic acid and metabo-lites in mouse plasma and brain following constant-rate applicationof the drug and its unsaturated metabolite with an osmotic deliverysystem[ J]. Biopharm Drug Dispos, 1982 ,3(4) : 317-328. 被引量:1
  • 10Wilimowska J, Klys M, Jawiefi W centrations of valproic acid (VPA) Analysis of variability of con- and its selected metabolites in the blood serum of patients treated with VPA and patients hospital- ized because of VPA poisoning [ J ]. Arch Med Sadowej Kryminol, 2014, 64(4) : 212-229. 被引量:1

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部